✦ LIBER ✦

A PHASE II STUDY TO EVALUATE THE EFFICACY AND TOLERABILITY OF INTRAVESICAL VICINIUM™ IN PATIENTS WITH CARCINOMA IN SITU (CIS) PREVIOUSLY TREATED WITH BACILLE CALMETTE-GUÉRIN (BCG): PRELIMINARY RESULTS

✍ Scribed by Kowalski, Mark; Jones, Nicola; Jewett, Michael AS; Cuthbert, Wendy; Glover, Nick; Andreou, Cal; Robertson, Cary N; Toguri, Allan

Book ID: 122461642
Publisher: Lippincott Williams and Wilkins
Year: 2008
Tongue: English
Weight: 130 KB
Volume: 179
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(08)61803-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

POD-07.03: Treatment With Intravesical V

POD-07.03: Treatment With Intravesical Vicinium™ Results in Durable Responses in Patients with Carcinoma In Situ (CIS) Previously Treated with Bacille Calmette-Guérin (BCG)

✍ M. Kowalski; N. Jones; M. Jewett; W. Cuthbert 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 146 KB

A Phase II Study of Oportuzumab Monatox:

A Phase II Study of Oportuzumab Monatox: An Immunotoxin Therapy for Patients with Noninvasive Urothelial Carcinoma In Situ Previously Treated with Bacillus Calmette-Guérin

✍ Kowalski, Mark; Guindon, Jacinthe; Brazas, Louise; Moore, Celine; Entwistle, Joy 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 397 KB

189 SEQUENTIAL CHEMO-IMMUNOTHERAPY WITH

189 SEQUENTIAL CHEMO-IMMUNOTHERAPY WITH MITOMYCIN C (MMC) AND BACILLUS CALMETTE-GUERIN (BCG) VERSUS BCG ALONE IN PATIENTS WITH CARCINOMA IN SITU (CIS) OF THE URINARY BLADDER. RESULTS OF EORTC GU GROUP RANDOMIZED PHASE II STUDY 30993

✍ W. Oosterlinck; Z. Kirkali; R.J. Sylvester; F. Calais Da Silva; C. Busch; F. Alg 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 83 KB

1474 SEQUENTIAL CHEMO-IMMUNOTHERAPY WITH

1474 SEQUENTIAL CHEMO-IMMUNOTHERAPY WITH MITOMYCIN C (MMC) AND BACILLUS CALMETTE-GUERIN (BCG) VERSUS BCG ALONE IN PATIENTS WITH CARCINOMA IN SITU (CIS) OF THE URINARY BLADDER. RESULTS OF EORTC GU GROUP RANDOMIZED PHASE II STUDY 30993

✍ Kirkali, Ziya; Oosterlinck, Willem; Sylvester, Richard; Calais Da Silva, Fernand 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 44 KB

Phase II study of intravesical therapy w

Phase II study of intravesical therapy with AD32 in patients with papillary urothelial carcinoma or carcinoma in situ (CIS) refractory to prior therapy with bacillus Calmette-Guerin (E3897): A trial of the Eastern Cooperative Oncology Group

✍ Jeffrey M. Ignatoff; Yu-Hui Chen; Richard Evan Greenberg; Julio M. Pow-Sang; Edw 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Long-Term Efficacy Results of EORTC Geni

Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

✍ Richard J. Sylvester; Maurizio A. Brausi; Wim J. Kirkels; Wolfgang Hoeltl; Ferna 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 408 KB